Back to 
Bank of Montreal
Bank of Montreal
AMLX
10 quarters
Position history for Bank of Montreal's holdings in Amylyx Pharmaceuticals, Inc.
No. Bank of Montreal exited its AMLX (Amylyx Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 138,525 shares worth $1.7M. Bank of Montreal first reported AMLX in Q2 2023 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.4M
Total Shares Change
-59,230
Quarter-by-Quarter History
Other major holders of AMLX: FMR LLC, Viking Global Investors LP